This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Iambic Therapeutics, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Joseph Dennis: Innovator in HER2 Modulation
Introduction
Joseph Dennis is a notable inventor based in San Diego, CA (US). He has made significant contributions to the field of biotechnology, particularly in the modulation of HER2, a protein that plays a critical role in the growth of certain cancer cells. His innovative work has the potential to impact cancer treatment and improve patient outcomes.
Latest Patents
Joseph Dennis holds 1 patent related to his research. The patent, titled "Compounds and methods for modulating HER2," discloses compounds of Formula (I) that are designed to effectively modulate the activity of HER2. This advancement could lead to new therapeutic strategies for treating HER2-positive cancers.
Career Highlights
Throughout his career, Joseph has been associated with Iambic Therapeutics, Inc., where he has focused on developing novel compounds for therapeutic applications. His work at the company underscores his commitment to advancing medical science and improving treatment options for patients.
Collaborations
Joseph has collaborated with talented professionals in his field, including Svitlana Kulyk and Shawn Wright. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.
Conclusion
Joseph Dennis is a dedicated inventor whose work in modulating HER2 represents a significant advancement in cancer treatment. His contributions to biotechnology and collaboration with fellow researchers highlight his commitment to improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile